Special Issue "Cancer Biomarker Research and Personalized Medicine"

Overview

Journal J Pers Med

Date 2022 Apr 23

PMID 35455701

Authors

James Meehan

Affiliations

Soon will be listed here.

Abstract

While the term biomarker is thought to have first been used in the 1970s, the concept itself is considered to be much older [...].

References

Meehan J, Gray M, Martinez-Perez C, Kay C, McLaren D, Turnbull A . Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine. J Pers Med. 2021; 11(7). PMC: 8306523. DOI: 10.3390/jpm11070664. View

Gray M, Marland J, Murray A, Argyle D, Potter M . Predictive and Diagnostic Biomarkers of Anastomotic Leakage: A Precision Medicine Approach for Colorectal Cancer Patients. J Pers Med. 2021; 11(6). PMC: 8229046. DOI: 10.3390/jpm11060471. View

Meehan J, Gray M, Martinez-Perez C, Kay C, Wills J, Kunkler I . A Novel Approach for the Discovery of Biomarkers of Radiotherapy Response in Breast Cancer. J Pers Med. 2021; 11(8). PMC: 8399231. DOI: 10.3390/jpm11080796. View

Payton C, Pang L, Gray M, Argyle D . Exosomes Derived from Radioresistant Breast Cancer Cells Promote Therapeutic Resistance in Naïve Recipient Cells. J Pers Med. 2021; 11(12). PMC: 8704086. DOI: 10.3390/jpm11121310. View

Jeong S, Kim U, Oh M, Nam J, Park S, Choi Y . Detection of Aberrant Glycosylation of Serum Haptoglobin for Gastric Cancer Diagnosis Using a Middle-Up-Down Glycoproteome Platform. J Pers Med. 2021; 11(6). PMC: 8235735. DOI: 10.3390/jpm11060575. View

Cheng S, Chen P, Ger T, Chiu H, Lin Y . Serves as a Potential Marker to Predict a Favorable Response in Triple-Negative Breast Cancer Patients Receiving a Taxane-Based Chemotherapy. J Pers Med. 2021; 11(3). PMC: 8001168. DOI: 10.3390/jpm11030197. View

Zuo D, An H, Li J, Xiao J, Ren L . The Application Value of Lipoprotein Particle Numbers in the Diagnosis of HBV-Related Hepatocellular Carcinoma with BCLC Stage 0-A. J Pers Med. 2021; 11(11). PMC: 8617679. DOI: 10.3390/jpm11111143. View

Moldovanu C, Boca B, Lebovici A, Tamas-Szora A, Feier D, Crisan N . Preoperative Predicting the WHO/ISUP Nuclear Grade of Clear Cell Renal Cell Carcinoma by Computed Tomography-Based Radiomics Features. J Pers Med. 2020; 11(1). PMC: 7822466. DOI: 10.3390/jpm11010008. View

Kang M, Lee J, Lee C, Park H, Jang K, Park S . IL13Rα2 Is Involved in the Progress of Renal Cell Carcinoma through the JAK2/FOXO3 Pathway. J Pers Med. 2021; 11(4). PMC: 8068290. DOI: 10.3390/jpm11040284. View

10.

Chang P, Wang H, Kuo Y, Lee L, Liao C, Kuo H . Circulating p16-Positive and p16-Negative Tumor Cells Serve as Independent Prognostic Indicators of Survival in Patients with Head and Neck Squamous Cell Carcinomas. J Pers Med. 2021; 11(11). PMC: 8624430. DOI: 10.3390/jpm11111156. View

11.

Rapado-Gonzalez O, Martinez-Reglero C, Salgado-Barreira A, Santos M, Lopez-Lopez R, Diaz-Lagares A . Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis. J Pers Med. 2021; 11(7). PMC: 8304899. DOI: 10.3390/jpm11070606. View

12.

Kalinina T, Kononchuk V, Alekseenok E, Abdullin G, Sidorov S, Ovchinnikov V . Associations between the Levels of Estradiol-, Progesterone-, and Testosterone-Sensitive MiRNAs and Main Clinicopathologic Features of Breast Cancer. J Pers Med. 2022; 12(1). PMC: 8779432. DOI: 10.3390/jpm12010004. View

13.

Benitez J, Campayo M, Diaz T, Ferrer C, Acosta-Plasencia M, Monzo M . Lincp21-RNA as Predictive Response Marker for Preoperative Chemoradiotherapy in Rectal Cancer. J Pers Med. 2021; 11(5). PMC: 8156811. DOI: 10.3390/jpm11050420. View

14.

Ingrosso G, Ali E, Marani S, Saldi S, Bellavita R, Aristei C . Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer. J Pers Med. 2022; 12(1). PMC: 8781984. DOI: 10.3390/jpm12010065. View

15.

Guldvik I, Ekseth L, Kishan A, Stensvold A, Inderberg E, Lilleby W . Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer. J Pers Med. 2021; 11(7). PMC: 8303369. DOI: 10.3390/jpm11070605. View

16.

Almuzzaini B, Alghamdi J, Alomani A, Alghamdi S, AlSharm A, AlShieban S . Identification of Novel Mutations in Colorectal Cancer Patients Using AmpliSeq Comprehensive Cancer Panel. J Pers Med. 2021; 11(6). PMC: 8230213. DOI: 10.3390/jpm11060535. View

17.

Rapado-Gonzalez O, Martinez-Reglero C, Salgado-Barreira A, Muinelo-Romay L, Muinelo-Lorenzo J, Lopez-Lopez R . Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis. J Pers Med. 2021; 11(6). PMC: 8233749. DOI: 10.3390/jpm11060568. View

18.

Martinez-Perez C, Leung J, Kay C, Meehan J, Gray M, Dixon J . The Signal Transducer IL6ST (gp130) as a Predictive and Prognostic Biomarker in Breast Cancer. J Pers Med. 2021; 11(7). PMC: 8304290. DOI: 10.3390/jpm11070618. View

19.

Kim K, Yu J, Park J, Baek S, Hwang J, Choi W . Low Preoperative Lymphocyte-to-Monocyte Ratio Is Predictive of the 5-Year Recurrence of Bladder Tumor after Transurethral Resection. J Pers Med. 2021; 11(10). PMC: 8540090. DOI: 10.3390/jpm11100947. View

20.

Gauthier A, Philouze P, Lauret A, Alphonse G, Malesys C, Ardail D . Circulating Tumor Cell Detection during Neoadjuvant Chemotherapy to Predict Early Response in Locally Advanced Oropharyngeal Cancers: A Prospective Pilot Study. J Pers Med. 2022; 12(3). PMC: 8950569. DOI: 10.3390/jpm12030445. View